Arai Y, Masuda A, Tsujimae M, Tobimatsu K, et al. Biological Borderline Resectable Pancreatic Cancer Represents a Genetically and
Immunologically Aggressive Subtype: A Retrospective Study. Ann Surg 2026 May 13. doi: 10.1097/SLA.0000000000007075.
PMID: 42121272
|